This document provides a summary of the IHS HIV Program update from May 2012. It includes:
1) An overview of AI/AN HIV epidemiology statistics such as incidence rates, number of people living with HIV, and AIDS diagnoses.
2) A discussion of new resources for the program including a new HIV epidemiology atlas and the IHS HIV/AIDS website.
3) An overview of current IHS HIV/AIDS Program initiatives funded by the Secretary's Minority AIDS Initiative such as enhanced health IT and clinical services.
4) A discussion of program performance measurement based on national HIV screening guidelines and future plans to expand testing and care linkages.
Presentation by Chloe Orkin, Royal London Hospital - BHIVA, United Kingdom, at AIDS 2018 conference during the joint ECDC and EACS satellite "Getting to 90: Addressing inequalities in the HIV continuum of care in Europe and Central Asia"
Presentation by Chloe Orkin, Royal London Hospital - BHIVA, United Kingdom, at AIDS 2018 conference during the joint ECDC and EACS satellite "Getting to 90: Addressing inequalities in the HIV continuum of care in Europe and Central Asia"
Representatives from the Philadelphia Department of Public Health (PDPH) presented an update on their strategic plan for sexual health at the February 2015 meeting of the Philadelphia Ryan White Part A Planning Council.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Amanda Mocroft, UCL
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Karen Champenois, Maison Blanche Hospital, Paris
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
This presentation on research about HIV self-testing in Australia was given by A/Prof Rebecca Guy, The Kirby Institute, at the AFAO Members Forum - May 2015.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Sophocles Chanos
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Representatives from the Philadelphia Department of Public Health (PDPH) presented an update on their strategic plan for sexual health at the February 2015 meeting of the Philadelphia Ryan White Part A Planning Council.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Amanda Mocroft, UCL
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Karen Champenois, Maison Blanche Hospital, Paris
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
This presentation on research about HIV self-testing in Australia was given by A/Prof Rebecca Guy, The Kirby Institute, at the AFAO Members Forum - May 2015.
Fast-track the end of AIDS in the EU - practical evidence-based interventions.
Presentation by: Sophocles Chanos
In a two-day meeting under the auspices of the Maltese Presidency of the Council of the European Union (30-31 January 2017), HIV experts from across the European Union discussed how to reverse this trend and how to prepare Europe to achieve the set target of ending AIDS by 2030.
Presentation by Andrew Forsyth, originally given at the HHS Region III Regional Resource Forum in Wilmington, Delaware in August 2015. Presented to the Philadelphia Ryan White Part A Planning Council in September.
The slides contain a brief review of NACP 1 through 4.
Key achievements and challenges of NACP Phase 4 have been mentioned. Further, Key strategies of national strategic plan for elimination of HIV/AIDS 2017-2024 has been discussed.
Improvement Story session at the 2013 Saskatchewan Health Care Quality Summit. For more information about the summit, visit www.qualitysummit.ca. Follow @QualitySummit on Twitter.
Better Care
Germain Bukassa Kazadi
OVC_HIVSTAT and Linkages to Care for Strengthened Collection, Analysis, and U...MEASURE Evaluation
This webinar focused on explaining the HIV Risk Assessment cascade and how it is related to OVC_HIVSTAT disaggregates. The presenters also provided guidance for how OVC_HIVSTAT data can be analyzed to enhance program outcomes.
The intersection of opioid use and HIV is well documented. More than one-third of all AIDS cases in the U.S. are directly or indirectly linked to injection drug use. Additionally, dependence and abuse of pain relievers is on the rise; people living with HIV/AIDS who suffer from chronic pain may be at particular risk. Opioids are highly addictive and mortality among illicit opioid users is estimated at 13 times that of the general population. The SPNS Buprenorphine Initiative investigated the effectiveness of integrating buprenorphine opioid abuse treatment into HIV primary care settings.
This Webcast is the first in a series under the new SPNS Integrating HIV Innovative Practices project (www.careacttarget.org/ihip) to assist providers in replicating SPNS work in their sites. This Webcast will introduce providers to the SPNS Buprenorphine Initiative, its findings, its synergy with the National HIV/AIDS Strategy, and provide an overview of opioid use and HIV.
The subsequent Webcast in the series will examine the clinical aspects of buprenorphine therapy, best practices, and implementation guidance. See also Integrating Buprenorphine Therapy Into HIV Primary Care Settings, a monograph on best practices, available at: https://careacttarget.org/content/integrating-buprenorphine-therapy-hiv-primary-care-settings.
Theodoros F. Katsivas, M.D., M.A.S., of UC San Diego Owen Clinic, presents "San Diego Primary Care Providers' Attitudes to HIV and HIV Testing" at AIDS Clinical Rounds
Boldly Using Technology to Change Culture around HIV Testing and Screening…YTH
Boldly using tech and social media to change the culture in LA around HIV testing and HIV screening Sin Verguenza (without shame). English, Spanish. Health Communications. Using social media for public health. Telenovela and soap opera series educating patients about the importance of HIV testing
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...YTH
Telemedicine is a collection of means or methods for enhancing health care, public health and health education delivery and support using telecommunications technologies. With more than 95% of adults, and 100% of young adults between the age of 18-29 owning a cell phone in the United States, a technology-based health intervention can be available to hard-to-reach populations or underserved areas.
Panelists will engage a rich dialogue and showcase innovative and effective ways to create prevention programs for HIV and STDs using the potential telehealth can offer, specifically with linking young people to HIV pre-exposure prophylaxis, or PrEP. This plenary brings together leaders in the field of HIV prevention, research and policy along with private organizations and companies that are currently active on the field of biomedical prevention.
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...YTH
Telemedicine is a collection of means or methods for enhancing health care, public health and health education delivery and support using telecommunications technologies. With more than 95% of adults, and 100% of young adults between the age of 18-29 owning a cell phone in the United States, a technology-based health intervention can be available to hard-to-reach populations or underserved areas.
Panelists will engage a rich dialogue and showcase innovative and effective ways to create prevention programs for HIV and STDs using the potential telehealth can offer, specifically with linking young people to HIV pre-exposure prophylaxis, or PrEP. This plenary brings together leaders in the field of HIV prevention, research and policy along with private organizations and companies that are currently active on the field of biomedical prevention.
Zimbabwe: Results-Based Financing Improves Coverage, Quality and Financial Pr...RBFHealth
A presentation by Dr. Gwinji, Permanent Secretary, Ministry of Health, Zimbabwe and Dr. Tafadzwa Goverwa- Sibanda, delivered during "Transforming Health Systems Through Results-Based Financing," an event held during the Third Global Symposium on Health Systems Research in Cape Town on September 30, 2014. This event was hosted by the Health Results Innovation Trust Fund at The World Bank, in partnership with the PBF Community of Practice in Africa.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
2. Discussion Overview
• Programmatic Update
– AI/AN Epidemiology
– New Resources
– IHS HIV/AIDS Program Initiatives
• Where We Are Headed
• Program Performance
2
4. AI/AN HIV Epidemiology
• HIV Estimates, 20091
– Incidence rate : 14.1/100K
– About 26% AI/AN People Living with HIV were estimated
to be unaware of status
• HIV Diagnosis, 20082
– Prevalence (# living with diagnosed HIV infection): 2,387
• AIDS Diagnosis, since 1985
– AI/AN ever diagnosed with AIDS (estimated): 3,7023
1
Estimated rates of new HIV infections, 50 U.S. states and the District of Columbia, 2009
2
Diagnosis from 40 states and 5 dependent areas, 2008
3
All states and 5 dependent areas, 2009
4
5. Rates of HIV Infection Diagnosis/ 100K*
(Adults/Adolescents/Children)
*40 states with long-term confidential name-based HIV infection reporting
5
Dependent areas not included due to limited census information
6. AI/AN HIV Epidemiology
• HIV diagnosis rate for AI/AN men (18.4 per 100K)
slightly higher than white men (14.8)
• HIV diagnosis rate for AI/AN women (6.6) more than
double the rate for white women (2.4)
6
Diagnosis from 40 states only, 2009
12. AIDS 2012
• IHS presence
• HUB opportunities
– Applications open now
– Applications close on September 15, 2012
– Recorded sessions will be available free of charge
– http://www.aids2012.org/hubs.aspx
• Technical Assistance
12
14. Major IHS HIV Initiatives
• Enhanced Medical Information Technology
• Patient-Centered Delivery of Medical Services/
Enhancing Continuity of Care
• Clinical Capacity Enhancements and Hepatitis
Integration into Care
• Effective Behavioral Interventions
• Media Interventions (esp. youth and LGBT)
• Continued Testing Expansions and Technical
Assistance
14
16. Where Are We Headed?
• Effective Behavioral Interventions Outcomes
Dissemination
• Expanded relationships with Tribes and
Communities: Including consultation
• Further expansion of HIV Testing
• Improving linkages to care, engagement in
care
• Improving integration with other IHS
programs and services
• Reporting, monitoring and evaluation of
programs: HHS Streamlining of Metrics
• Further growth of the HIV network in I/T/U 16
18. 4 Performance Measures
2010
1. HIV Screening of 13-64 y.o.: 7%
2. Prenatal HIV Screening (GPRA): 82%
3. Comprehensive of STI+ patients: 31%
4. Chlamydia screening of sexually active 15-24
y.o. females annually: 26%
All 4 measures based on national guidelines and
recommendations
18
21. Successful Screening
• Sites understand screening rationale
• Use of standing protocols or clinical
reminders for patients eligible for
screening
• Medical team comfortable offering HIV test
and test results
• Clear responsibility for who offers HIV test
• Clear linkage to care for HIV+
• Generally “provider-endorsed, nurse-
driven”
24. Deploying Reminders
(AK site method)
1) Pilot test and refine with 1-2 providers
2) Deploy reminder with all providers
3) Data feedback for providers to teams to see
screening scores (iCare)
4) Delegate screenings away from physicians
5) Each professional only sees a subset of total
reminders
source: Onders et. al. JAMIA [in press]
25.
26. New measure
• HCV screening, once only, birth cohort of
persons born 1945-1965
• Already incorporated in CRS logic as
national indicator
26
27. Thank You
Lisa C. Neel, MPH
Program Analyst, HIV Program
IHS Headquarters
801 Thompson Ave, Suite 304B
Rockville, MD 20852
(301) 443-4305
lisa.neel@ihs.gov
http://www.ihs.gov/hivaids/
27
Editor's Notes
Introduce yourself properly. Acknowledge VIPS.
Talking Points The first step in understanding HIV is screening for it, because the disease is silent for so long. Low prevalence and low incidence do not mean “no one.” To improve our care to Tribes, the IHS has increased overall screening throughout our system by 45% since the year 2000. Success has been particularly pronounced in prenatal screening. Last year, we documented a prenatal screening rate of 86%. Sources Prejean J, Song R, Hernandez A, Ziebell R, Green T, et al. (2011) Estimated HIV Incidence in the United States, 2006-2009 . PLoS ONE 6(8): e17502.doi:10.1371/journal.pone.0017502 - 26% PLWHA Unaware, estimated 2006 ( J Acquir Immune Defic Syndr. 2010 Apr;53(5):619-24.) AI/AN People Living with HIV, 2008 AI/AN People ever diagnosed with AIDS 2009: 3,702 ( All states and 5 dependent areas: Table 2b of http://www.cdc.gov/hiv/surveillance/resources/reports/2009report/index.htm)
References: http://www.cdc.gov/hiv/surveillance/resources/reports/2009report/pdf/table1a.pdf Plausible Reasons? Changes in state reporting regulations. Increased Testing Instability of data. The increase appeared mostly in 2007. Most recent year is always least stable. Possible increase in HIV diagnosis
HIV Diagnosis Rate per 100K ( Table 3a: http://www.cdc.gov/hiv/surveillance/resources/reports/2009report/index.htm) Men, 2009 AI/AN White Women, 2009 AI/AN White
Talking Points: As you can see, the survival time for AI/AN people is the lowest of all groups among people who have an AIDS diagnosis. We have made a conscious decision within the agency to not allow epidemiology to determine fate. References: All 50 states plus District of Columbia Table 14a of http://www.cdc.gov/hiv/surveillance/resources/reports/2009report/index.htm
even if you cannot make it to Washington D.C in person, you can still bring the momentum, expertise, and materials from the global conference to your community by hosting an AIDS 2012 conference hub. These conference hubs are “mini conferences” held in conjunction with the international conference by local organizations active in the AIDS response. Sessions from AIDS 2012 will be recorded or telecast free of charge for selected applicants and can be screened at organizers’ discretion. These sessions are typically followed by moderated discussions with local or regional experts to examine how the session content can be used to strengthen the HIV/AIDS response. You can download and complete the hub ’ s application form in English and email completed forms to hubs@aids2012.org. For more information on hosting a conference hub please visit www.aids2012.org/hubs.aspx or contact hubs@aids2012.org.
This is a map of the HIV/AIDS Programs FY 2009 partnerships. It will be updated soon to reflect more recent additions. This map is available online on our website: I encourage you to review it for potential partnerships in your area. Please note that screening for HIV is offered in many more sites as part of medical care: these are only the sites with expanded HIV-specific programs. Care and treatment for HIV infection is offered in some sites and referred out in others.
2000-2007 numbers are from the Other National Measures report for 2008, representing 70 Federal and 81 Tribal sites that reported. 2000: 12,042 2007: 46,679 2008: 51,052 (151 sites, 81 Tribal and 70 IHS) 2009: 57,630 (162 sites, 93 Tribal and 69 IHS) 2010: 67,749 (196 sites, 130 Tribal and 66 IHS)
The following updates should be made to the year/percent information: 2005: 54% 2006: 65% 2007: 74% 2008: 75% 2009: 76% (new column) 2010: 78% Source: GPRA Data 2005-2010, Dr. Amy Patterson Personal Communication 12/15/2010